Log in
Enquire now
‌

US Patent 9145396 Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine

Patent 9145396 was granted and assigned to Targacept, Inc. on September, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
‌
Targacept, Inc.
Current Assignee
‌
Targacept, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9145396
Date of Patent
September 29, 2015
Patent Application Number
14074147
Date Filed
November 7, 2013
Patent Citations Received
‌
US Patent 11911380 Compositions and use of varenicline for treating dry eye
0
‌
US Patent 11903943 Compositions and use of varenicline for treating dry eye
0
‌
US Patent 11903941 Compositions and use of varenicline for treating dry eye
0
‌
US Patent 11903942 Compositions and use of varenicline for treating dry eye
0
Patent Primary Examiner
‌
Deepak Rao
Patent abstract

The present invention relates to the stereospecific synthesis of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidine, its salt forms, and novel polymorphic forms of these salts.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9145396 Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.